Suppr超能文献

[转移性类癌瘤的两年干扰素治疗]

[2 year interferon therapy of metastatic carcinoid tumor].

作者信息

von Scheidt W, Böhm M, Huber I, Habersetzer R, Jacob K, Markl A, Autenrieth G

机构信息

Medizinische Klinik I, Klinikum Grosshadern, Universität München.

出版信息

Klin Wochenschr. 1990 Feb 15;68(4):241-6. doi: 10.1007/BF01662725.

Abstract

A 39 year old male patient was treated with daily 5 X 10(6) IU interferon alpha 2b s.c. for 22 months because of advanced carcinoid tumor. Objective response was achieved with greater than 50% reduction of 5-HIAA-excretion. Multiple metastases (liver, lung, bones, thyroid gland) were not progressing in size. An unintentional omission of treatment resulted in a rapid biochemical and morphological tumor progression. Reversibility was achieved with reinstitution of effective interferon therapy. Thus, interferon therapy of advanced carcinoid tumor is able to induce a long-term objective response. It seems to be superior to conventional chemotherapy.

摘要

一名39岁男性患者因晚期类癌瘤接受每日5×10(6)国际单位的干扰素α-2b皮下注射治疗,持续22个月。实现了客观缓解,5-羟吲哚乙酸排泄量减少超过50%。多处转移灶(肝脏、肺、骨骼、甲状腺)的大小没有进展。治疗的意外中断导致肿瘤在生化和形态学上迅速进展。重新开始有效的干扰素治疗后实现了逆转。因此,晚期类癌瘤的干扰素治疗能够诱导长期的客观缓解。它似乎优于传统化疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验